- Most therapeutic peptides are prescription-only medicines in Australia, regulated by the TGA under Schedule 4 of the Poisons Standard.
- Several growth hormone-releasing peptides are prohibited in sport by ASADA and WADA, regardless of whether you hold a prescription.
- BPC-157 is not a TGA-registered medicine; products sold for human use without approval are not legally available in Australia.
- If you are using prescribed peptides, regular blood testing including IGF-1, liver enzymes, and fasting glucose is strongly recommended.
- Any decision to start peptide therapy should begin with a consultation with a registered medical practitioner, not an online supplier.
- Blood monitoring gives you objective data to assess whether a prescribed treatment is working and whether any markers need attention.
What Is a Peptide, and Why Are Australians Searching for Them?
Interest in using a peptide in Australia has grown sharply over the last few years, driven largely by fitness communities, longevity enthusiasts, and athletes looking for an edge in recovery and body composition. But the term "peptide" covers an enormous range of compounds, and the regulatory and safety picture is far more nuanced than most online content suggests.
At the most basic level, a peptide is a short chain of amino acids. Proteins are also chains of amino acids, but peptides are shorter, typically fewer than 50 amino acids in length.[7] Because they are small and structurally specific, many peptides act as signalling molecules in the body, binding to receptors and triggering downstream effects on growth hormone release, tissue repair, inflammation, metabolism, and more.
The peptides that attract the most interest in performance and recovery contexts include growth hormone secretagogues (substances that prompt the pituitary gland to release growth hormone), repair-focused compounds like BPC-157, and metabolic peptides. Each sits in a different regulatory category, and understanding that distinction matters before you consider anything further.
The Regulatory Reality: TGA and the Poisons Standard
Australia's Therapeutic Goods Administration (TGA) regulates all medicines sold or used in Australia, including peptides with a therapeutic purpose. The majority of peptides that have documented biological activity in humans are classified under Schedule 4 of the Poisons Standard, meaning they are prescription-only medicines.[2]
This classification exists for good reasons. Prescription status means a registered medical practitioner must assess your individual circumstances, determine whether the treatment is appropriate, and issue a valid prescription. It also means the product must come from a licensed pharmacy or compounding pharmacist working within TGA guidelines.
The TGA's framework for biological medicines and peptides sets out what is required for a peptide to be registered as a therapeutic good in Australia.[1] Crucially, many peptides being marketed and sold online have no TGA registration at all. Purchasing unregistered therapeutic goods for human use is illegal under the Therapeutic Goods Act 1989, regardless of what the seller's website claims.
Compounding and the Special Access Scheme
Two pathways exist for accessing peptides that are not commercially registered in Australia. First, a compounding pharmacist can prepare a peptide medicine on the basis of a valid prescription from a registered practitioner. Second, the TGA's Special Access Scheme (SAS) allows prescribers to apply for access to unapproved therapeutic goods for individual patients in specific circumstances. Neither pathway applies to self-prescribing or online purchases from overseas suppliers.
Growth Hormone Peptides and Sport: The ASADA Position
For competitive athletes, the legal picture has an additional layer. The Australian Sports Anti-Doping Authority (ASADA) enforces the World Anti-Doping Agency (WADA) Prohibited List in Australia.[3] Growth hormone-releasing factors, including peptides such as CJC-1295, ipamorelin, and related compounds, appear on the WADA Prohibited List under the category of peptide hormones, growth factors, and related substances.[4]
This prohibition applies both in-competition and out-of-competition for many substances in this class. Holding a valid prescription does not exempt an athlete from an anti-doping rule violation if the substance is on the Prohibited List. If you compete in a sport governed by a WADA-compliant code, you must check the Prohibited List and consult with your national federation before using any prescribed peptide.
BPC-157 in Australia: A Specific Case
BPC-157 is one of the most widely discussed peptides in Australian fitness communities. It is a synthetic peptide derived from a sequence found in human gastric juice, and animal studies have examined its potential effects on tissue repair and recovery. However, it is not a TGA-registered medicine in Australia, and it is not approved for human use.[1]
Products marketed online as BPC-157 for human consumption do not have TGA approval. Supplying or purchasing such products for therapeutic use is inconsistent with Australian therapeutic goods law. A small number of compounding pharmacists may prepare it under a practitioner prescription with appropriate justification, but this is distinct from buying vials from overseas peptide suppliers.
The important distinction here is that animal or in-vitro research on a compound does not translate directly into safety or efficacy data for humans. Before any compound is approved for human use in Australia, the TGA requires clinical evidence of quality, safety, and efficacy.
What Blood Markers Should You Monitor?
If you are working with a medical practitioner who has prescribed a peptide therapy for a legitimate clinical reason, blood monitoring is a standard component of responsible management. The specific markers depend on the compound and the clinical context, but several are broadly relevant.
IGF-1 (Insulin-Like Growth Factor 1)
Growth hormone-releasing peptides work by stimulating the pituitary gland to secrete growth hormone. Growth hormone in turn stimulates the liver to produce IGF-1, which mediates many of growth hormone's downstream effects. Monitoring IGF-1 levels gives your doctor a functional readout of the biological effect of the treatment.[5]
Reference intervals for IGF-1 are age- and sex-dependent. Levels outside the normal range can indicate either insufficient effect or overactivation, and chronically elevated IGF-1 is associated with increased health risks. This is one reason monitoring matters.
Fasting Glucose and Insulin Sensitivity
Growth hormone has well-documented effects on glucose metabolism. At supraphysiological levels, it can reduce insulin sensitivity and elevate fasting glucose.[7] If you are using a growth hormone-related peptide under medical supervision, your doctor may want to track fasting glucose, HbA1c, or a fasting insulin level to ensure your metabolic profile stays within a healthy range.
Liver Enzymes
Some peptides are associated with changes in liver enzyme activity. Monitoring ALT, AST, and GGT provides a window into liver health during any treatment programme.[6] Understanding your gamma-GT (GGT) level as a marker of liver stress is covered in detail in our GGT blood test explainer.
Full Blood Count and Hormonal Panel
Depending on the peptide and the clinical indication, your prescribing doctor may also want to track haemoglobin, haematocrit, and other markers that could shift with changes in growth hormone axis activity. A broader hormonal panel may include testosterone, cortisol, and thyroid function to give a complete picture of how your endocrine system is responding.
If you are new to monitoring your blood markers and want to understand what a comprehensive panel looks like, our guide to getting a blood test without a referral in Australia explains the options available to you.
Where People Go Wrong
The biggest risk in the current peptide landscape in Australia is not the compounds themselves. It is the sourcing and the absence of medical oversight.
Several online suppliers market peptides openly to Australian consumers, often as "research chemicals" to sidestep therapeutic goods law. These products are not subject to TGA quality controls, which means the actual peptide content, purity, and sterility cannot be verified. Independent testing of products sold by overseas suppliers has repeatedly found mislabelled concentrations and contamination.
Using an unverified injectable compound without medical supervision carries risks that cannot be managed through online research. Injection site reactions, systemic infections, and unknown metabolic effects are all real possibilities when quality assurance is absent.
A second common mistake is treating peptide use as a substitute for addressing the fundamentals that blood testing can reveal. Poor sleep, suboptimal nutrition, low vitamin D, iron deficiency, and thyroid dysfunction are all measurable, treatable causes of the fatigue, slow recovery, and body composition issues that many people seek peptides to address. Testing first is a rational approach.
When to see a GP first: If your interest in peptides is driven by fatigue, poor recovery, low libido, or difficulty building muscle, these symptoms warrant a thorough blood workup before any therapeutic intervention. Many of these concerns have identifiable, treatable causes that a blood panel can reveal. Book an appointment with your GP or use a private testing service to get a baseline before considering any prescription treatment.
A Note on Overseas Purchasing
Importing prescription medicines into Australia without a valid TGA-approved import permit is generally prohibited under the Therapeutic Goods Act 1989. The TGA's personal importation scheme allows travellers to bring limited quantities of their own prescription medicines into the country, but it does not extend to ordering unregistered prescription compounds from overseas suppliers for ongoing use. Packages can be seized by Border Force, and the purchaser may face legal consequences.
The Sensible Starting Point
If you have a genuine clinical reason to explore peptide therapy, the right starting point is a consultation with a registered medical practitioner who has experience in this area. They can assess whether a peptide is appropriate for your situation, prescribe through a legitimate channel if warranted, and put a monitoring plan in place.
If you are simply curious about your baseline health, where your hormones, metabolic markers, and recovery indicators currently sit, blood testing is a straightforward, non-invasive first step. It gives you real data rather than assumptions, and it often reveals that the fundamentals need attention before anything more involved is considered.
FAQ
Are peptides legal in Australia?
Most therapeutic peptides are classified as prescription-only medicines (Schedule 4) under Australian law and must be obtained through a licensed pharmacy with a valid prescription from a registered medical practitioner. Several growth hormone-releasing peptides are also prohibited in sport under ASADA and WADA rules, regardless of prescription status. Purchasing unregistered peptide products from overseas suppliers for human use is inconsistent with Australian therapeutic goods law.
Do you need a prescription for peptides in Australia?
Yes, in almost all cases. If a peptide has therapeutic activity in humans, the TGA classifies it as a prescription medicine. A registered doctor must assess you and determine the clinical justification before a prescription can be issued. Products sold online without this process are not legally sourced prescription medicines.
What blood tests should I monitor if I am using prescribed peptides?
The specific panel depends on the compound and the clinical reason for use, but commonly tracked markers include IGF-1, fasting glucose, HbA1c, liver enzymes (ALT, AST, and GGT), and a full blood count. Your prescribing doctor should outline a monitoring schedule suited to your treatment.
Is BPC-157 available in Australia?
BPC-157 does not have TGA registration as a therapeutic good for human use in Australia. It may be prepared by a compounding pharmacist on the basis of a valid practitioner prescription with appropriate clinical justification, but it is not available as an over-the-counter or online purchase for therapeutic use.
Can peptides affect blood test results?
Yes. Growth hormone-releasing peptides can elevate IGF-1, affect fasting glucose and insulin sensitivity, and in some cases alter liver enzyme levels. Regular blood monitoring is a standard component of medically supervised peptide therapy and helps ensure the treatment is achieving its intended effect without causing adverse changes to other markers.
